(ANSA) – MOSCOW, May 06 – A single-dose version of the Sputnik V vaccine, called Sputnik Light, has been registered in Russia. This was announced by the Russian Direct Investment Fund (Rdif) in a note.
The statement reads, “The single-dose Sputnik Lite vaccine showed an efficacy of 79.4% according to the data analyzed after 28 injections within the framework of the Russian comprehensive vaccination program between December 5, 2020 and April 15, 2021.” It reads, “The level of effectiveness is approximately 80% higher than that of many two-dose vaccines. Sputnik Light has been shown to be effective against all new strains of the coronavirus, as explained by the Aesthetic Center during laboratory tests.”
“On February 21, 2021, the Aesthetics Center and Rudev launched a global efficacy study for Sputnik Light. The third phase of the clinical trial, involving 7,000 people, is taking place in several countries including Russia, the United Arab Emirates, Ghana and others. Provisional results are expected in May 2021.”
“Sputnik Light will help prevent the spread of the coronavirus through faster immunization for larger populations, as well as support higher levels of immunity in those who have been previously infected,” said Alexander Ginsburg, Director of the Aesthetic Center. “Sputnik Light offers powerful value in initial vaccination and revaccination, as well as enhancing efficacy when taken with other vaccines.” (handle).
Reproduction is reserved © Copyright ANSA